A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company with a market capitalization of $311.86 billion, has been at the forefront of the industry with its diverse portfolio of pharmaceuticals ...

Karyopharm Therapeutics Inc. (NASDAQ:KPTI), a biotechnology company focused on developing novel cancer treatments, stands at ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Behind the blinding white light of Monday's trillion–dollar AI wipeout that was a spot of unabashedly good AI news.

Alan Tan, MD, discusses factors influencing the choice of immunotherapy plus tyrosine kinase inhibitor vs dual IO in patients ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer ...

With the breakthrough of hospital-at-home came greater acceptance of higher acuity care in the community setting. With this ...

IDEXX Laboratories shared earlier this month the launch of IDEXX Cancer Dx, a diagnostic panel with early detection of ...

An analysis of ctDNA testing for early detection of recurrence showed that test had high sensitivity across multiple sites of ...

The cost of cancer may be higher than previously estimated, according to a recent report from the American Cancer Society.

Dr. Alan C. Hartford is an expert in oncology, the field of medicine focusing on the diagnosis, treatment, prevention and ...